• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
FNCH

FNCH

Finch Therapeutics Group, Inc.

OTCHealthcareBiotechnologyUS

USD7.45

+0.00 (+0.00%)

Company Profile

CEO

Matthew Blischak

IPO Date

2021-03-19

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

Country

US

Market Metrics

Open

$7.45

Prev. Close

$7.45

Day Low

$7.45

Day High

$7.45

52W Low

$2.00

52W High

$16.10

Market Cap

$0.01B

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

5

Avg Positive

15.0%

Avg Negative

1.2%

Avg Neutral

83.8%

News Feed

Finch Therapeutics Added to Russell 2000 and Russell 3000 Indexes

GlobeNewsWire·6/28/2021·↑ positive

Finch Therapeutics: Gut Instinct Says Buy

Seeking Alpha·6/14/2021·↑ positive

Finch Therapeutics to Present at Upcoming Virtual Investor Conferences

GlobeNewsWire·5/28/2021·↑ positive

Finch Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Updates

GlobeNewsWire·5/13/2021·↑ positive

Finch Therapeutics Announces Pricing of Upsized Initial Public Offering

GlobeNewsWire·3/18/2021·↑ positive